National HealthCare Corporation filings document operating results, dividend actions, governance matters and capital-structure disclosures for a publicly traded senior health care company. The company’s 8-K reports include earnings releases, quarterly common dividend announcements, director appointments and other material-event disclosures, with NHC common stock registered on the NYSE American.
Proxy materials cover annual meeting matters, shareholder voting, board structure and committee governance. The filing record also describes NHC’s skilled nursing, senior living, behavioral health, home care, hospice, pharmacy, rehabilitation and third-party management activities, along with financial reporting topics such as GAAP and non-GAAP results, marketable equity securities and acquired White Oak operations.
Robert G. Adams, a director of National HealthCare Corp (NHC), exercised options and acquired shares on 09/19/2025. He exercised 4,500 options from a 2021 grant at an exercise price of $71.64, resulting in the acquisition of 4,500 shares reported as an acquisition at $71.64 per share.
The filing shows Mr. Adams beneficially owns 13,579 shares following the transaction through a trust and holds indirect interests through a partnership position of 430,341 shares as general partner. The report also lists outstanding options granted in 2022, 2023, 2024 and 2025, each for 7,500 shares, with varying exercise prices and expiration dates.
National HealthCare Corporation's tenant subsidiary has been notified by its landlord, National Health Investors, Inc., of alleged non-compliance with four non-monetary provisions of a Master Lease covering 35 facilities. The landlord's September 8, 2025 letter asserts a default and invoked the lease cure provisions, giving the tenant thirty days to cure or risk an Event of Default. The tenant disputes that the alleged matters constitute defaults, says it has proceeded with reasonable diligence to address any issues, and is negotiating with the landlord. The Master Lease currently runs through December 31, 2026, with two five-year renewal options and a right of first refusal to purchase leased properties; termination that removes renewal rights could have a material adverse effect on NHC's financial condition.
Stephen Flatt, CEO and director of National Healthcare Corp. (NHC), reported multiple equity transactions on 08/22/2025. He exercised stock options and acquired 4,000 shares in two option exercises at strike prices of $53.94 and $94.10, and the filings show withholding of 3,146 shares to cover exercise costs and taxes at an effective price of $114.82 per share. After these transactions, Flatt beneficially owns between 59,393 and 61,393 common shares depending on the line item referenced. The exercises relate to grants from the 2020 Omnibus Equity Incentive Plan dated March 8, 2023 and March 5, 2024.
J. Paul Abernathy, a director of National Healthcare Corp. (NHC), reported exercising stock options and a related share withholding on August 13, 2025. He exercised options granted May 6, 2021, resulting in the acquisition of 4,010 shares at an exercise price implied by the filing of $71.64 per share. Simultaneously, 2,639 shares were withheld by the company to satisfy the exercise price, leaving Mr. Abernathy with 39,033 shares beneficially owned after the transactions. The filing lists outstanding option grants from 2022, 2023, 2024 and 2025, each covering 7,500 options with exercise prices from $69.19 to $96.03 and standard exercisability/expiration schedules.
Josh A. McCreary, Senior VP & General Counsel of National Healthcare Corp. (NHC), exercised stock options and reported related share withholding. On 08/13/2025 Mr. McCreary exercised 4,000 options with an exercise price of $53.94, resulting in 4,000 shares acquired. To cover the exercise price and withholding taxes, the company withheld 2,737 shares at an implied price of $108.82. After these transactions, Mr. McCreary beneficially owned 9,716 shares of NHC common stock.
The exercised options were part of a grant from the 2020 Omnibus Equity Incentive Plan issued on 03/08/2023 and are exempt from Section 16(b) under Rule 16b-3(d). The Form 4 was signed 08/15/2025 and reports both non-derivative and derivative holdings, including existing options exercisable through 2030.
National HealthCare Corporation filed a current report to disclose that it issued a press release on August 8, 2025 announcing its earnings for the period ended June 30, 2025. The company states that the full earnings press release is provided as Exhibit 99.1 and is incorporated by reference, meaning the detailed financial results and commentary are contained in that attached document rather than in this summary filing.
National HealthCare Corporation (NHC) filed a Form 8-K dated 8 Aug 2025 reporting Item 8.01 – Other Events. The filing states that on 7 Aug 2025 the company issued a press release announcing its quarterly common-stock dividend. The press release is furnished as Exhibit 99.1 and is incorporated by reference. No dividend amount, record date, or payment date is disclosed within the 8-K itself, and no additional financial data or material transactions are presented.